The current report also shows the diversity in human colon cancer tissues in terms of degree of CBS expression; colon cancers which exhibit high CBS expression proliferate faster when placed in PDTX models than the low CBS-expressor PDTX counterparts, and respond better to the CBS inhibitor’s antiproliferative effect. The gene discussed is CBS; the disease is malignant colon neoplasm.